Search Results - "Olnes, Matthew"
-
1
Global analyses of human immune variation reveal baseline predictors of postvaccination responses
Published in Cell (10-04-2014)“…A major goal of systems biology is the development of models that accurately predict responses to perturbation. Constructing such models requires the…”
Get full text
Journal Article -
2
Recent advances in immune therapies for gastric cancer
Published in Cancer gene therapy (01-09-2021)“…Gastric cancer (GC) is an aggressive malignancy that is the third leading cause of cancer mortality worldwide. Localized GC can be cured with surgery, but most…”
Get full text
Journal Article -
3
Eltrombopag restores trilineage hematopoiesis in refractory severe aplastic anemia that can be sustained on discontinuation of drug
Published in Blood (20-03-2014)“…About a quarter of patients with severe aplastic anemia remain pancytopenic despite immunosuppressive therapy. We have previously demonstrated that eltrombopag…”
Get full text
Journal Article -
4
Immune Therapies for Hematologic Malignancies
Published in Cancers (15-01-2021)“…The era of immunotherapy for hematologic malignancies began with the first allogeneic hematopoietic stem cell transplant (HSCT) study published by E [...]…”
Get full text
Journal Article -
5
Thrombopoietin receptor agonists for marrow failure: A concise clinical review
Published in Best practice & research. Clinical haematology (01-06-2021)“…Bone marrow failure is characterized by a disruption of hematopoietic stem cell (HSC) homeostasis and function, which causes decreased blood counts. Germline…”
Get full text
Journal Article -
6
Eltrombopag and Improved Hematopoiesis in Refractory Aplastic Anemia
Published in The New England journal of medicine (05-07-2012)“…A phase 2 study showed a 44% response rate with eltrombopag, an oral thrombopoietin mimetic, among 25 patients with refractory aplastic anemia. Severe aplastic…”
Get full text
Journal Article -
7
Baseline levels and temporal stability of 27 multiplexed serum cytokine concentrations in healthy subjects
Published in PloS one (12-12-2013)“…Cytokines are humoral molecules that elicit regulatory function in immunologic pathways. The level and type of cytokine production has become critical in…”
Get full text
Journal Article -
8
Effects of Systemically Administered Hydrocortisone on the Human Immunome
Published in Scientific reports (14-03-2016)“…Corticosteroids have been used for decades to modulate inflammation therapeutically, yet there is a paucity of data on their effects in humans. We examined the…”
Get full text
Journal Article -
9
Immune Therapies for Myelodysplastic Syndromes and Acute Myeloid Leukemia
Published in Cancers (08-10-2021)“…Myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) are hematologic malignancies arising from the bone marrow. Despite recent advances in treating…”
Get full text
Journal Article -
10
Gastric cancer in Alaska Native people: A cancer health disparity
Published in World journal of gastroenterology : WJG (07-07-2018)“…To evaluate recent trends in gastric cancer incidence, response to treatment, and overall survival among Alaska Native (AN) people. A retrospective analysis of…”
Get full text
Journal Article -
11
Eltrombopag monotherapy can improve hematopoiesis in patients with low to intermediate risk-1 myelodysplastic syndrome
Published in Haematologica (Roma) (01-12-2020)“…Myelodysplastic syndromes (MDS) are a group of clonal myeloid disorders characterized by cytopenia and a propensity to develop acute myeloid leukemia (AML)…”
Get full text
Journal Article -
12
Eltrombopag monotherapy can improve hematopoiesis in patients with low to intermediate risk-1 myelodysplastic syndrome
Published in Haematologica (Roma) (01-12-2020)“…Myelodysplastic syndromes (MDS) are a group of clonal myeloid disorders characterized by cytopenia and a propensity to develop acute myeloid leukemia (AML)…”
Get full text
Journal Article -
13
Ultra-low Dose Interleukin-2 Promotes Immune-modulating Function of Regulatory T Cells and Natural Killer Cells in Healthy Volunteers
Published in Molecular therapy (01-07-2014)“…Low-dose interleukin-2 (IL-2) expands regulatory T cells (Tregs) and natural killer (NK) cells after stem cell transplantation (SCT) and may reduce…”
Get full text
Journal Article -
14
Molecular Classification of Gastric Cancer among Alaska Native People
Published in Cancers (13-01-2020)“…Gastric cancer is an aggressive and heterogeneous malignancy that often varies in presentation and disease among racial and ethnic groups. The Alaska Native…”
Get full text
Journal Article -
15
Alemtuzumab Treatment of Intermediate-1 Myelodysplasia Patients Is Associated With Sustained Improvement in Blood Counts and Cytogenetic Remissions
Published in Journal of clinical oncology (10-12-2010)“…Myelodysplastic syndromes (MDS) are characterized by ineffective hematopoiesis and progression to leukemia. Clinical and experimental evidence suggests an…”
Get full text
Journal Article -
16
Targeting Immune Dysregulation in Myelodysplastic Syndromes
Published in JAMA (23-02-2011)“…Myelodysplastic syndromes (MDS) are a heterogeneous group of bone marrow disorders characterized by ineffective hematopoiesis and a tendency to develop…”
Get full text
Journal Article Conference Proceeding -
17
Acute and persistent responses after H5N1 vaccination in humans
Published in Cell reports (Cambridge) (24-09-2024)“…To gain insight into how an adjuvant impacts vaccination responses, we use systems immunology to study human H5N1 influenza vaccination with or without the…”
Get full text
Journal Article -
18
A review and update on cholangiocarcinoma
Published in Oncology (01-01-2004)“…Cholangiocarcinoma is a malignant neoplasm arising from the biliary epithelium that was first described by Durand-Fardel in 1840. Today, it continues to defy…”
Get more information
Journal Article -
19
-
20
Persistent elevation of plasma thrombopoietin levels after treatment in severe aplastic anemia
Published in Experimental hematology (01-02-2018)“…Although hematopoietic growth factors are found at high levels in aplastic anemia (AA) patients, little is known about their dynamic change over time after…”
Get full text
Journal Article